Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-28T08:52:17.291Z Has data issue: false hasContentIssue false
  • English
  • Français

Development of a Surveillance System for Methicillin-Resistant Staphylococcus aureus in German Hospitals

Published online by Cambridge University Press:  02 January 2015

Iris F. Chaberny ,
Dorit Sohr ,
Henning Rüden  and
Petra Gastmeier
Iris F. Chaberny*
Affiliation:
Institute of Medical Microbiologyand Hospital Epidemiology, Medical School Hannover, Germany German National Reference Center for Surveillance of Nosocomial Infections, Germany
Dorit Sohr
Affiliation:
Institute of Hygiene and Environmental Medicine, Charité-University Medicine, Free University and Humboldt University Berlin, Germany German National Reference Center for Surveillance of Nosocomial Infections, Germany
Henning Rüden
Affiliation:
Institute of Hygiene and Environmental Medicine, Charité-University Medicine, Free University and Humboldt University Berlin, Germany German National Reference Center for Surveillance of Nosocomial Infections, Germany
Petra Gastmeier
Affiliation:
Institute of Medical Microbiologyand Hospital Epidemiology, Medical School Hannover, Germany German National Reference Center for Surveillance of Nosocomial Infections, Germany
*
Medical School Hannover, Institute of Medical Microbiology andHospital Epidemiology, Carl-Neuberg-Str. 1, D-30625 Hannover ([email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective.

To determine the appropriate method to calculate the rate of methicillin-resistant Staphylococcus aureus (MRSA) infection and colonization (hereafter, MRSA rates) for interhospital comparisons, such that the large number of patients who are already MRSA positive on admission is taken into account.

Design.

A prospective, multicenter, hospital-based surveillance of MRSA-positive case patients from January through December 2004.

Setting.

Data from 31 hospitals participating in the German national nosocomial infections surveillance system (KISS) were recorded during routine surveillance by the infection control team at each hospital.

Results.

Data for 4,215 MRSA-positive case patients were evaluated. From this data, the following values were calculated. The median incidence density was 0.71 MRSA-positive case patients per 1,000 patient-days, and the median nosocomial incidence density was 0.27 patients with nosocomial MRSA infection or colonization per 1,000 patient-days (95% CI, 0.18-0.34). The median average daily MRSA burden was 1.13 MRSA patient-days per 100 patient-days (95% CI, 0.86-1.51), with the average daily MRSA burden defined as the total number of MRSA patient-days divided by the total number of patient-days times 100. The median MRSA-days–associated nosocomial MRSA infection and colonization rate, which describes the MRSA infection risk for other patients in hospitals housing large numbers of MRSA-positive patients and/or many patients who were MRSA positive on admission, was 23.1 cases of nosocomial MRSA infection and colonization per 1,000 MRSA patient-days (95% CI, 17.4-28.6). The values were also calculated for various MRSA screening levels.

Conclusions.

The MRSA-days–associated nosocomial MRSA rate allows investigators to assess the extent of MRSA colonization and infection at each hospital, taking into account cases that have been imported from other hospitals, as well as from the community. This information provides an appropriate incentive for hospitals to introduce further infection control measures.

Type
Original Article
Information
Infection Control & Hospital Epidemiology , Volume 28 , Issue 4 , April 2007 , pp. 446 - 452
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004;32:470–485.Google Scholar
2.EARSS. European Antimicrobiol Resistance Surveillance System. Annual Report. Bilthoven: ESCMID; 2002.Google Scholar
3.Global consensus conference: final recommendations. Am J Infect Control 1999;27:503–513.Google Scholar
4.Abramson, MA, Sexton, DJ. Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: at what costs? Infect Control Hosp Epidemiol 1999;20:408–411.Google Scholar
5.Cosgrove, SE, Sakoulas, G, Perencevich, EN, Schwaber, MJ, Karchmer, AW, Carmeli, Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003;36:53–59.Google Scholar
6.Engemann, JJ, Carmeli, Y, Cosgrove, SE, et al.Adverse clinical and economic outcomes attributable to mefhicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 2003;36:592–598.Google Scholar
7.Kirkland, KB, Weinstein, JM. Adverse effects of contact isolation. Lancet 1999;354:1177–1178.Google Scholar
8.Whitby, M, McLaws, ML, Berry, G. Risk of death from methicillin-resistant Staphylococcus aureus bacteraemia: a meta-analysis. Med J Aust 2001;175:264–267.Google Scholar
9.Chaberny, IF, Ziesing, S, Mattner, F, et al.The burden of MRSA in four German university hospitals. Int J Hyg Environ Health 2005;208:447–453.Google Scholar
10.Tiemersma, EW, Bronzwaer, SL, Lyytikainen, O, et al.Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002. Emerg Infect Dis 2004;10:1627–1634.Google Scholar
11. German National Reference Center for Surveillance of Nosocomial Infections (Nationales Referenzzentrum für Surveillance von nosokomialen Infektionen [NRZ]). Available at: http://www.nrz-hygiene.de. Accessed March 3, 2007.Google Scholar
12.Empfehlung zur Prävention und Kontrolle von Methicillin-resistenten Staphylococcus aureus-Stämmen (MRSA) in Krankenhäusern und anderen medizinischen Einrichtungen: Mitteilung der Kommission für Krankenhaushygiene und Infektionsprävention am Robert Koch-Institut. Bundesgesundheitsblatt 1999;42:954–958.Google Scholar
13.Jarvis, WR, Edwards, JR, Culver, DH, et al.Nosocomial infection rates in adult and pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System. Am J Med 1991;91:185S–191S.Google Scholar
14.Merrer, J, Santoli, F, Appere de Vecchi, C, Tran, B, De Jonghe, B, Outin, H. “Colonization pressure” and risk of acquisition of methicillin-resistant Staphylococcus aureus in a medical intensive care unit. Infect Control Hosp Epidemiol 2000;21:718–723.Google Scholar
15.Haley, RW. Surveillance by objective: a new priority-directed approach to the control of nosocomial infections. The National Foundation for Infectious Diseases lecture. Am J Infect Control 1985;13:78–89.Google Scholar
16.Kresken, M, Hafner, D, Schmitz, F-J, Wichelhaus, TA. Resistenzsituation bei klinisch wichtigen Infektionserregern gegenüber Antibiotika in Deutschland und im mitteleuropäischen Raum: Bericht über die Ergebnisse einer multizentrischen Studie der Arbeitsgemeinschaft Empfindlichkeitsprüfungen und Resistenz der Paul-Ehrlich-Gesellschaft für Chemotherapie e.V. aus dem Jahre 2001. Antiinfectives Intelligence, Rheinbach 2006;1:14–15. Available at http://www.p-e-g.org/ag_resistenz/main.htm. Accessed March 3, 2007.Google Scholar
17.Gastmeier, P, Sohr, D, Geffers, C, Nassauer, A, Dettenkofer, M, Ruden, H. Occurrence of methicillin-resistant Staphylococcus aureus infections in German intensive care units. Infection 2002;30:198–202.Google Scholar
18.The Hopital Propre II Study Group. Methicillin-resistant Staphylococcus aureus in French hospitals: a 2-month survey in 43 hospitals, 1995. Infect Control Hosp Epidemiol 1999;20:478–486.Google Scholar
19.Eveillard, M, Schmit, JL, Biendo, M, et al.Evaluation of the efficacy of a multiresistant bacteria control programme in a teaching hospital, studying the evolution of methicillin-resistant Staphylococcus aureus incidence [in French]. Pathol Biol (Paris) 2002;50:538–543.Google Scholar
20.Lepelletier, D, Richet, H. Surveillance and control of methicillin-resistant Staphylococcus aureus infections in French hospitals. Infect Control Hosp Epidemiol 2001;22:677–682.Google Scholar
21.McDonald, P, Mitchell, E, Johnson, H, et al.Epidemiology of MRSA: the North/South study of MRSA in Ireland 1999. J Hosp Infect 2003;54:130–134.Google Scholar
22.Albertini, MT, Benoit, C, Berardi, L, et al.Surveillance of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae producing extended-spectrum beta-lactamase (ESBLE) in Northern France: a five-year multicentre incidence study. J Hosp Infect 2002;52:107–113.Google Scholar
23.Assadian, O, Daxboeck, F, Aspoeck, C, Blacky, A, Dunkl, R, Koller, W. National surveillance of methicillin-sensitive and methicillin-resistant Staphylococcus aureus in Austrian hospitals: 1994-1998. J Hosp Infect 2001;55:175–179.Google Scholar
24.Simor, AE, Ofner-Agostini, M, Bryce, E, Green, K, McGeer, A, Mulvey, M, Paton, S. The evolution of methicillin-resistant Staphylococcus aureus in Canadian hospitals: 5 years of national surveillance. CMAJ 2001;165:21–26.Google Scholar
25.Struelens, MJ, Ronveaux, O, Jans, B, Mertens, R. Methicillin-resistant Staphylococcus aureus epidemiology and control in Belgian hospitals, 1991 to 1995. Groupement pour le Depistage, l'Etude et la Prevention des Infections Hospitalieres. Infect Control Hosp Epidemiol 1996;17:503–508.Google Scholar
26.Bonten, MJ, Slaughter, S, Ambergen, AW, et al.The role of “colonization pressure” in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med 1998;158:1127–1132.Google Scholar
27.Lucet, JC, Paoletti, X, Lolom, I, et al.Successful long-term program for controlling methicillin-resistant Staphylococcus aureus in intensive care units. Intensive Care Med 2005;31:1051–1057.CrossRefGoogle ScholarPubMed
28.Eveillard, M, Lancien, E, Hidri, N, et al.Estimation of methicillin-resistant Staphylococcus aureus transmission by considering colonization pressure at the time of hospital admission. J Hosp Infect 2005;60:27–31.CrossRefGoogle ScholarPubMed
29.Pittet, D, Safran, E, Harbarth, S, et al.Automatic alerts for methicillin-resistant Staphylococcus aureus surveillance and control: role of a hospital information system. Infect Control Hosp Epidemiol 1996;17:496–502.Google Scholar